Cargando…

Biologics for atopic diseases: Indication, side effect management, and new developments

With the advent of biologicals, more and more therapeutics are available that specifically address specific switch points in the pathomechanism of immunologically dominated diseases. Thus, the focus of diagnostics and therapy (precision medicine) is more on the individual disease characteristics of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jappe, Uta, Beckert, Hendrik, Bergmann, Karl-Christian, Gülsen, Askin, Klimek, Ludger , Philipp, Sandra, Pickert, Julia, Rauber-Ellinghaus, Michèle M., Renz, Harald, Taube, Christian, Treudler, Regina, Wagenmann, Martin, Werfel, Thomas, Worm, Margita, Zuberbier, Torsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787364/ https://www.ncbi.nlm.nih.gov/pubmed/33426426 http://dx.doi.org/10.5414/ALX02197E

Ejemplares similares

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology
por: Pfaar, Oliver, et al.
Publicado: (2022)

Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences
por: Kleine-Tebbe, Jörg, et al.
Publicado: (2021)

COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)
por: Pfaar, Oliver, et al.
Publicado: (2021)

COVID-19 vaccination and allergen immunotherapy (AIT) – A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
por: Klimek, Ludger, et al.
Publicado: (2021)

Food allergies resulting from immunological cross-reactivity with inhalant allergens: Guidelines from the German Society for Allergology and Clinical Immunology (DGAKI), the German Dermatology Society (DDG), the Association of German Allergologists (AeDA) and the Society for Pediatric Allergology and Environmental Medicine (GPA)
por: Worm, Margitta, et al.
Publicado: (2014)

COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika): Ein Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und dem Ärzteverband Deutscher Allergologen (AeDA)
por: Pfaar, Oliver, et al.
Publicado: (2021)

Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events*
por: Gülsen, Askin, et al.
Publicado: (2020)

Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events
por: Gülsen, Askin, et al.
Publicado: (2020)

Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis
por: Gülsen, Askin, et al.
Publicado: (2021)

Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (Æ-GAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF)
por: Worm, Margitta, et al.
Publicado: (2015)

Update of the S2k guideline on the management of IgE-mediated food allergies
por: Worm, Margitta, et al.
Publicado: (2021)

Biologika und Covid-19
por: Buhl, Roland, et al.
Publicado: (2020)

Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
por: Lee, Hae-Hyuk, et al.
Publicado: (2007)

Guideline on management of suspected adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergology and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA) as well as the Swiss Society for Allergology and Immunology (SGAI) and the Austrian Society for Allergology and Immunology (ÖGAI)
por: Reese, Imke, et al.
Publicado: (2021)

Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis
por: Gülsen, Askin, et al.
Publicado: (2021)

Nonpharmacological measures to prevent allergic symptoms in pollen allergy: A critical review
por: Bergmann, Karl-Christian, et al.
Publicado: (2021)

Schwere allergische Reaktionen nach COVID-19-Impfung mit dem Impfstoff von Pfizer/BioNTech in Großbritannien und USA: Stellungnahme der deutschen allergologischen Gesellschaften AeDA (Ärzteverband Deutscher Allergologen), DGAKI (Deutsche Gesellschaft für Allergologie und klinische Immunologie) und GPA (Gesellschaft für Pädiatrische Allergologie und Umweltmedizin)
por: Klimek, Ludger, et al.
Publicado: (2021)

Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)
por: Klimek, Ludger, et al.
Publicado: (2021)

Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie: Ein Positionspapier des Ärzteverbandes Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C und des Deutschen Allergie- und Asthmabundes (DAAB)D
por: Klimek, Ludger, et al.
Publicado: (2020)

Developing integrated care pathways for atopic dermatitis—Challenges and unmet needs
por: Zuberbier, Torsten, et al.
Publicado: (2023)

German guideline for the management of adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Association of Allergologists (AeDA), and the Swiss Society for Allergology and Immunology (SGAI)
por: Reese, Imke, et al.
Publicado: (2017)

Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written
por: Klimek, Ludger, et al.
Publicado: (2015)

282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

Precision medicine reaching out to the patients in allergology – a German-Japanese workshop report
por: Pfaar, Oliver, et al.
Publicado: (2021)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Glukokortikoide und Covid-19
por: Klimek, Ludger, et al.
Publicado: (2020)

Risk of sensitization and allergy in Ragweed workers – a pilot study
por: Brandt, Oliver, et al.
Publicado: (2014)

A novel experimental technology for testing efficacy of air purifiers on pollen reduction
por: Bergmann, Karl-Christian, et al.
Publicado: (2016)

Allergiekongress in Dresden: Aufbruch zu einem allergologischen Klimawandel
por: Klimek, Ludger, et al.
Publicado: (2021)

Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019)

Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany
por: Worm, Margitta, et al.
Publicado: (2021)

Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany
por: Brehler, Randolf, et al.
Publicado: (2016)

Praktischer Umgang mit allergischen Reaktionen auf COVID-19-Impfstoffe: Ein Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA), der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) und der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)
por: Klimek, Ludger, et al.
Publicado: (2021)

Autoallergy in atopic dermatitis
por: Hradetzky, Susanne, et al.
Publicado: (2015)

Mund-Nasen-Masken zur Vermeidung von COVID-19 und Pollenallergie geeignet: eine Studie in der Expositionskammer
por: Bergmann, Karl-Christian, et al.
Publicado: (2021)

Face masks suitable for preventing COVID-19 and pollen allergy. A study in the exposure chamber
por: Bergmann, Karl-Christian, et al.
Publicado: (2021)

Role of Macrophages in the Pathogenesis of Atopic Dermatitis
por: Kasraie, Sadaf, et al.
Publicado: (2013)

Vegan diets from an allergy point of view – Position paper of the DGAKI working group on food allergy
por: Reese, Imke, et al.
Publicado: (2023)

Course of respiratory allergy by treatment strategy based on German routine data
por: Weschenfelder, Ann-Kathrin, et al.
Publicado: (2017)

Atopic dermatitis and psychosocial comorbidities – What’s new?
por: Kage, Paula, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_edtqstb3leqk5kgrqvpdlhqen1